Asb Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.99 Cr
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
- Revenue Growth -100.00%
- Profit Growth 85.01%
- Ebitda 99.63%
- Net Worth -3.42%
- Total Assets -3.17%
About Asb Laboratories
Asb Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 2006 and has a history of 18 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Elbs Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.99 Cr.
The company currently has active open charges totaling ₹9.00 M.
Alluru Saibabu and Meghna Alluru serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24119TG2006PTC051653
- Company No.
051653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Asb Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alluru Saibabu  | Director | 14-Nov-2006 | Current |
| Meghna Alluru | Director | 05-Jan-2023 | Current |
Financial Performance of Asb Laboratories.
Asb Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 85.01% increase in profit. The company's net worth dipped by a decrease of 3.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asb Laboratories?
Unlock access to Asb Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Asb Homes Private LimitedAlluru Saibabu and Meghna Alluru are mutual person
Charges (Loans)
₹0.90 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2016 | Others | ₹9.00 M | Open |
How Many Employees Work at Asb Laboratories?
Unlock and access historical data on people associated with Asb Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asb Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asb Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
